Pulse Biosciences Inc PLSE
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-05-18 |
| Shares Out. | 69,210,000 |
| Website | pulsebiosciences.com/ ↗ |
| Phone | 13026587581 |
| Employees | 116 |
| Revenue | $401,000 |
| Gross Profit | $31,000 |
| Net Income | -$18.6M |
| Free Cash Flow | -$55.5M |
| Total Assets | $81.6M |
| Total Liabilities | $15.3M |
| Equity | $66.3M |
About Pulse Biosciences Inc
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Pulse Biosciences Inc is a publicly traded company under the ticker symbol PLSE on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)